22-41382081-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_003216.4(TEF):​c.37G>A​(p.Asp13Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000185 in 1,079,696 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000019 ( 0 hom. )

Consequence

TEF
NM_003216.4 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.47

Publications

0 publications found
Variant links:
Genes affected
TEF (HGNC:11722): (TEF transcription factor, PAR bZIP family member) This gene encodes a member of the PAR (proline and acidic amino acid-rich) subfamily of basic region/leucine zipper (bZIP) transcription factors. It is expressed in a broad range of cells and tissues in adult animals, however, during embryonic development, TEF expression appears to be restricted to the developing anterior pituitary gland, coincident with the appearance of thyroid-stimulating hormone, beta (TSHB). Indeed, TEF can bind to, and transactivate the TSHB promoter. It shows homology (in the functional domains) with other members of the PAR-bZIP subfamily of transcription factors, which include albumin D box-binding protein (DBP), human hepatic leukemia factor (HLF) and chicken vitellogenin gene-binding protein (VBP); VBP is considered the chicken homologue of TEF. Different members of the subfamily can readily form heterodimers, and share DNA-binding, and transcriptional regulatory properties. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11187345).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TEFNM_003216.4 linkc.37G>A p.Asp13Asn missense_variant Exon 1 of 4 ENST00000266304.9 NP_003207.1 Q10587-1
TEFNM_001145398.3 linkc.68-5270G>A intron_variant Intron 1 of 3 NP_001138870.1 Q10587-2
LOC105373042XR_938271.3 linkn.-170C>T upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TEFENST00000266304.9 linkc.37G>A p.Asp13Asn missense_variant Exon 1 of 4 1 NM_003216.4 ENSP00000266304.4 Q10587-1
TEFENST00000406644.7 linkc.68-5270G>A intron_variant Intron 1 of 3 2 ENSP00000385256.3 Q10587-2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000185
AC:
2
AN:
1079696
Hom.:
0
Cov.:
32
AF XY:
0.00000392
AC XY:
2
AN XY:
509712
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22962
American (AMR)
AF:
0.00
AC:
0
AN:
8406
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14348
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26516
South Asian (SAS)
AF:
0.00
AC:
0
AN:
19542
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
21108
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3298
European-Non Finnish (NFE)
AF:
0.00000217
AC:
2
AN:
919842
Other (OTH)
AF:
0.00
AC:
0
AN:
43674
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 25, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.37G>A (p.D13N) alteration is located in exon 1 (coding exon 1) of the TEF gene. This alteration results from a G to A substitution at nucleotide position 37, causing the aspartic acid (D) at amino acid position 13 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.45
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.24
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.57
T
M_CAP
Pathogenic
0.37
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
3.5
PrimateAI
Pathogenic
0.93
D
PROVEAN
Benign
0.18
N
REVEL
Benign
0.17
Sift
Benign
0.072
T
Sift4G
Benign
0.11
T
Polyphen
0.0
B
Vest4
0.14
MutPred
0.10
Gain of glycosylation at P11 (P = 0.0974);
MVP
0.12
MPC
0.99
ClinPred
0.53
D
GERP RS
4.3
PromoterAI
0.0055
Neutral
Varity_R
0.19
gMVP
0.19
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr22-41778085; API